Aier Eye Hospital Group's Fiscal Year is From January To December - All Figures are in CNY, Millions.
The item "Research-and-Development" stands at 312.89 Million Chinese Yuans for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2023.
Aier Eye Hospital Group's third quarter result of 70.57 Million CNY for the item "Research and Development" represents a decrease of -7.22 percent compared to it's second quarter result.
Also, Aier Eye Hospital Group's third quarter result of 70.57 Million CNY for the item "Research and Development" represents a decrease of -16.49 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Aier Eye Hospital Group's third quarter result of 312.89 Million CNY for the item "Research and Development" represents a decrease of -4.26 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.41 percent compared to the value the year prior.
The 1 year change in percent is -2.41.
The 3 year change in percent is 17.02.
The 5 year change in percent is 126.59.
The 10 year change in percent is 2,144.71.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | HCA Holdings Inc - Research and Development | 113,884,643,328.00 |
![]() | Fresenius SE & Co. KGaA - Research and Development | 30,755,373,246.51 |
![]() | Tenet Healthcare Corporation - Research and Development | 18,553,710,592.00 |
![]() | IHH Healthcare Bhd - Research and Development | 18,158,397,709.45 |
![]() | Universal Health Services Inc - Research and Development | 14,705,629,184.00 |